Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.09 USD
Change Today 0.00 / 0.00%
Volume 0.0
FNAM On Other Exchanges
As of 8:10 PM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

fona inc (FNAM) Snapshot

Previous Close
Day High
Day Low
52 Week High
08/12/14 - $0.28
52 Week Low
07/7/15 - $0.09
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for FONA INC (FNAM)

Related News

No related news articles were found.

fona inc (FNAM) Related Businessweek News

No Related Businessweek News Found

fona inc (FNAM) Details

Fona, Inc. does not have significant operations. The company intends to locate and consummate a merger or acquisition with a private entity. Previously, it was engaged in the provision of Internet-based Rent411 services. The company was formerly known as Fonahome Corporation and changed its name to Fona, Inc. in March 2009. Fona, Inc. was incorporated in 1990 and is based in Castle Rock, Colorado. Fona, Inc. is a subsidiary of Evolutionary Genomics, Inc.

fona inc (FNAM) Top Compensated Officers

Chairman of The Board, Chief Executive Office...
Total Annual Compensation: $120.0K
Secretary and Treasurer
Total Annual Compensation: $142.4K
Compensation as of Fiscal Year 2014.

fona inc (FNAM) Key Developments

Fona, Inc. Auditor Raises 'Going Concern' Doubt

Fona, Inc. filed its 10-K on Mar 05, 2015 for the period ending Dec 31, 2014. In this report its auditor, Schumacher & Associates, Inc, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Fona, Inc. Announces Management Changes

Virginia Orndorff and Mark Boggess were appointed as directors of the Fona, Inc. by the Board, effective 10 days after an information statement on Schedule 14F-1 is mailed to the company's shareholders and (ii) Messrs. Friess and Schwartz's voluntarily resigned as officers and directors of the company, effective immediately. Mr. Friess, the company's President and principal executive officer, resigned from such positions on October 1, 2014. Steve B. Warnecke was appointed Chief Financial Officer, Treasurer, Secretary and member of the board of directors of Fona on June 6, 2014, and became its principal executive officer as President, Chief Executive Officer and Chairman of the Board on October 1, 2014. Mr. Warnecke has served as a member of the board of directors of Evolutionary Genomics since September 2010 and was appointed as Chief Executive Officer in November 2010. Since November 2012, Mr. Warnecke has served part-time roles as Chairman of the Board of Directors and Chief Financial Officer for VetDC, Inc. and Senior Vice President of Children's Hospital Colorado Foundation and Chairman of Children's Partners Foundation (supporting Children's Hospitals and cystic fibrosis research) since November 2011. He also is a member of the Board of Directors of CereScan and Bone Biologics, Inc. Virginia Orndorff was appointed as a director of the company on October 1, 2014. She has served as a member of the Evolutionary Genomics board of directors since 2000. Since 2012 Ms. Orndorff has served as Chief Executive Officer of SixOne Solutions, LLC. She also currently serves on Colorado's State Board of Pharmacy since 2012. Mark Boggess, Ph.D. was appointed as a director of the company on October 1, 2014. He has served as a director of Evolutionary Genomics since 2009. Dr. Boggess has a diverse background in the animal sciences and animal industries. Currently, Dr. Boggess serves as the Director of the U.S. Dairy Forage Research Center in Madison, WI. Walter Messier, Ph.D. was appointed Secretary and Treasurer of the company on October 1, 2014. He is a Founder of Evolutionary Genomics and has served as its Chief Technology Officer since 2000 and has served as its Secretary since 2007.

Fona, Inc. announced delayed 10-Q filing

On 08/14/2014, Fona, Inc. announced that they will be unable to file their next 10-Q by the deadline required by the SEC.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
FNAM:US $0.09 USD 0.00

FNAM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for FNAM.
View Industry Companies

Industry Analysis


Industry Average

Valuation FNAM Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book NM Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact FONA INC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at